Your browser doesn't support javascript.
loading
Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression.
Boiko, Dmytro I; Shkodina, Anastasiia D; Hasan, Mohammad Mehedi; Bardhan, Mainak; Kazmi, Syeda Kanza; Chopra, Hitesh; Bhutra, Prerna; Baig, Atif Amin; Skrypnikov, Andrii M.
Afiliación
  • Boiko DI; Department of Psychiatry, Narcology and Medical Psychology, Poltava State Medical University, Poltava, Ukraine.
  • Shkodina AD; Department of Nervous Diseases with Neurosurgery and Medical Genetics, Poltava State Medical University, Poltava, Ukraine.
  • Hasan MM; Neurological Department, Municipal Enterprise "1 City Clinical Hospital of Poltava City Council", Poltava, Ukraine.
  • Bardhan M; Department of Biochemistry and Molecular Biology, Faculty of Life Science, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh.
  • Kazmi SK; Department of Neurology, National Institute of Mental Health And Neurosciences (NIMHANS), Bengaluru, India.
  • Chopra H; Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
  • Bhutra P; Chitkara College of Pharmacy, Chitkara University, Punjab, India. chopraontheride@gmail.com.
  • Baig AA; GMERS Medical College and Hospital, Sola, Ahmedabad, Gujarat, India.
  • Skrypnikov AM; Faculty of Medicine, Universiti Sultan Zainal Abidin, Terengganu, Malaysia. atifamin@unisza.edu.my.
Neurochem Res ; 47(10): 2909-2924, 2022 Oct.
Article en En | MEDLINE | ID: mdl-35689787

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Melatonina Idioma: En Revista: Neurochem Res Año: 2022 Tipo del documento: Article País de afiliación: Ucrania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Melatonina Idioma: En Revista: Neurochem Res Año: 2022 Tipo del documento: Article País de afiliación: Ucrania